High Tower Advisors, LLC Athira Pharma, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 12,697 shares of ATHA stock, worth $3,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,697
Previous 12,697
-0.0%
Holding current value
$3,809
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATHA
# of Institutions
61Shares Held
18.4MCall Options Held
14.3KPut Options Held
4.4K-
Perceptive Advisors LLC New York, NY5.4MShares$1.62 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.2MShares$960,2000.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$461,3740.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$447,8370.49% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$447,8370.02% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $11.3M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...